tradingkey.logo
tradingkey.logo
Suchen

Avalon Globocare Corp

ALBT
Zur Watchlist hinzufügen
0.282USD
-0.009-3.09%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
2.35MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Avalon Globocare Corp Unternehmen

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.

Avalon Globocare Corp Informationen

BörsenkürzelALBT
Name des UnternehmensAvalon Globocare Corp
IPO-datumFeb 22, 2016
CEOJin (David)
Anzahl der mitarbeiter5
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 22
Addresse4400 Route 9
StadtFREEHOLD
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07728
Telefon17327804400
Websitehttps://www.avalon-globocare.com/
BörsenkürzelALBT
IPO-datumFeb 22, 2016
CEOJin (David)

Führungskräfte von Avalon Globocare Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Avalon Globocare Corp?

Die fünf größten Anteilseigner von Avalon Globocare Corp sind: Mr. Wenzhao (Daniel) Lu

Wie viele Institutionen halten Anteile an Avalon Globocare Corp (ALBT)?

Mit Stand vom 2026Q1 halten 30 Institutionen Anteile an Avalon Globocare Corp, mit einem Gesamtmarktwert von etwa 83.03K, was 1.00% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -43859.00 gestiegen.